Women who have had breast cancer treatment may be at increased risk for osteoporosis and fracture. Estrogen has a protective effect on bone, and reduced levels of the hormone trigger bone loss.
Breast cancer is one of the most common cancers. Almost 25 percent of people newly diagnosed with cancer have breast cancer. One in 5 people with breast cancer have a type called HER2-positive.
All women have BRCA1 and BRCA2 genes, but only some women have mutations in those genes.
Doctors and scientists are always looking for better ways to care for people with breast cancer. To make scientific advances, doctors design research studies involving volunteers, called clinical trials. In fact, every drug that is now approved by the U.S. Food and Drug Administration (FDA) was tested in clinical trials.
Los cánceres de seno triple negativos no contienen receptores de estrógeno ni de progesterona. Tampoco producen exceso de proteína HER2. Debido a que las células cancerosas carecen de estas proteínas, las opciones de tratamiento para el cáncer de seno triple negativo son limitadas.
What is triple-negative breast cancer?
What are breast calcifications? How are they found? Do they increase my risk of breast cancer?
In a study published in Cancer Research, BCRF researchers Drs. Jill Bargonetti and Funmi Olopade report a possible new treatment strategy that targets vulnerabilities in triple-negative breast cancer (TNBC), a particularly aggressive form of the disease with limited treatment options.
For the first time, a study has shown that exercise has a direct biological effect on breast tumor gene expression...
What to Know & What to Ask your Health Care Providers about Textured Implants